You searched for joep lange - Page 18 of 20

01 Jan Public-private partnerships and new models of healthcare access

Posted at 00:00h

Authored by: Lange Joep M. A., Schellekens Onno P., Lindner Marianne, van der Gaag JacquesIn: CURRENT OPINION IN HIV AND AIDS 3(4), 2008, p.509-513http://www.ncbi.nlm.nih.gov/pubmed/19373013

01 Jan Late entry to HIV care limits the impact of anti-retroviral therapy in The Netherlands

Posted at 00:00h

Authored by: Smit Colette, Hallett Timothy B., Lange Joep, Garnett Geoff, de Wolf FrankIn: PLOS ONE 3(4), 2008, p.e1949-http://www.ncbi.nlm.nih.gov/pubmed/18398473

07 Dec Pending questions in the treatment of HIV 1 infection

Posted at 00:00h

Authored by: Katalin Pogány Thesis Universiteit van Amsterdam Promotor(s): Lange Joep MA Copromotor(s): Prins J. M. http://www.ncbi.nlm.nih.gov/pubmed/10173802 Date of thesis defence: 07/12/2007

19 Oct Highly active antiretroviral therapy in non indigenous patients in the Netherlands

Posted at 00:00h

Authored by: J. F. J. B. Nellen Thesis Universiteit van Amsterdam Promotor(s): Lange Joep M. A. Copromotor(s): Prins J. M., Wit Ferdinand W. N. M. Date of thesis defence: 19/10/2007

05 Oct Antiretroviral therapy: efficacy and toxicity in the ARES study and responses in the male genital tract

Posted at 00:00h

Authored by: Selwyn H. Lowe Thesis Universiteit van Amsterdam Promotor(s): Lange Joep M. A., Borleffs Jan C. C. Copromotor(s): Prins Jan M. ISBN: 9789052786513 Date of thesis defence: 05/10/2007 Read more

25 Jan Mitochondrial toxicity of HIV 1 infection and its treatment

Posted at 00:00h

Authored by: M. Casula M Thesis Universiteit van Amsterdam Promotor(s): Reiss Peter, Lange Joep M. A. Copromotor(s): de Ronde Anthony, Wit Ferdinand W. N. M. ISBN: 9789090214757 Date of thesis defence: 25/01/2007

01 Jan A phase I/IIa study with succinylated human serum albumin (Suc-HSA), a candidate HIV-1 fusion inhibitor

Posted at 00:00h

Authored by: Vermeulen Joost N., Meijer Dirk K. F., Over Jan, Lange Joep M. A., Proost Johannes H., Bakker Hester I., Beljaars Leonie, Wit Ferdinand W. N. M., Prins Jan M.In: ANTIVIRAL THERAPY 12(2), 2007, p.273-278http://www.ncbi.nlm.nih.gov/pubmed/17503670

01 Jan Stavudine but not didanosine as part of HAART contributes to peripheral lipoatrophy: a substudy from the Antiretroviral Regimen Evaluation Study (ARES)

Posted at 00:00h

Authored by: Lowe Selwyn H., Hassink Elly A. M., van Eck-Smit Berthe L. F., Borleffs Jan C. C., Lange Joep M. A., Reiss PeterIn: HIV CLINICAL TRIALS 8(5), 2007, p.337-344http://www.ncbi.nlm.nih.gov/pubmed/17956835

01 Jan Intravenous immunoglobulin (IVIG) treatment for modulation of immune activation in human immunodeficiency virus type 1 infected therapy-naive individuals

Posted at 00:00h

Authored by: Vermeulen Joost N., Prins Jan M., Bunnik Evelien, Hack C. Erik, Jurriaans Suzanne, Miedema Frank, Lange Joep M. A., Schuitemaker HannekeIn: AIDS RESEARCH AND HUMAN RETROVIRUSES 23(11), 2007, p.1348-1353http://www.ncbi.nlm.nih.gov/pubmed/18184076

01 Jan Semen quality and drug concentrations in seminal plasma of patients using a didanosine or didanosine plus tenofovir containing antiretroviral regimen

Posted at 00:00h

Authored by: Lowe Selwyn H., van Leeuwen Elisabeth, Droste Jacqueline A. H., van der Veen Fulco, Reiss Peter, Lange Joep M. A., Burger David M., Repping Sjoerd, Prins Jan M.In: THERAPEUTIC DRUG MONITORING 29(5), 2007, p.566-570http://www.ncbi.nlm.nih.gov/pubmed/17898645

Search

01 Jan Public-private partnerships and new models of healthcare access

01 Jan Late entry to HIV care limits the impact of anti-retroviral therapy in The Netherlands

07 Dec Pending questions in the treatment of HIV 1 infection

19 Oct Highly active antiretroviral therapy in non indigenous patients in the Netherlands

05 Oct Antiretroviral therapy: efficacy and toxicity in the ARES study and responses in the male genital tract

25 Jan Mitochondrial toxicity of HIV 1 infection and its treatment

01 Jan A phase I/IIa study with succinylated human serum albumin (Suc-HSA), a candidate HIV-1 fusion inhibitor

01 Jan Stavudine but not didanosine as part of HAART contributes to peripheral lipoatrophy: a substudy from the Antiretroviral Regimen Evaluation Study (ARES)

01 Jan Intravenous immunoglobulin (IVIG) treatment for modulation of immune activation in human immunodeficiency virus type 1 infected therapy-naive individuals

01 Jan Semen quality and drug concentrations in seminal plasma of patients using a didanosine or didanosine plus tenofovir containing antiretroviral regimen

Contact

QUICK LINKS